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a b s t r a c t
Background: Atrial tissue ﬁbrosis has previously been identiﬁed using delayed-enhancement MRI (DE-MRI) in
patients with atrial ﬁbrillation (AF). Although the clinical importance of DE-MRI is well recognized, the
visualization of atrial ﬁbrosis and radiofrequency (RF) lesions has still not been achieved in Japan, primarily
because of the differences in contrast agents, volume-rendering tools, and technical experience. The objective
of this study was to visualize RF lesions by using commercially available tools.
Methods: DE-MRI was performed in 15 patients who had undergone AF ablation (age, 5974 years, left atrium
diameter, 4072mm). Speciﬁc parameters for MR scanning obtained from previous reports were modiﬁed.
Results: Of the 15 images, the images of three patients were uninterpretable owing to low image quality. RF
lesions could be visualized in 8 (67%) of the 12 patients.
Conclusions: In the current study, we successfully demonstrated that RF lesions could be visualized in Japanese
patients using DE-MRI, although only commercially available tools were used.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Delayed-enhancement magnetic resonance imaging (DE-MRI) is an
established method for characterizing cardiac tissue in various disease
processes [1]. Recently, DE-MRI has emerged as an effective method
for noninvasively assessing and quantifying the extent of left atrium
(LA) structural remodeling [2], which has been reported to be
independent of the type of atrial ﬁbrillation (AF) and associated
comorbidities. Moreover, selecting appropriate treatment candi-
dates based on the quality and quantity of atrial ﬁbrosis detected
using DE-MRI has shown to improve the procedural outcome and
prevent unnecessary interventions [3]. Furthermore, a multicenter
trial has also demonstrated that atrial ﬁbrosis, as estimated by DE-
MRI, is independently associated with the likelihood of recurrent
arrhythmias [4]. We recognize the use and importance of DE-MRI
for visualizing atrial ﬁbrosis [3]. However, neither atrial ﬁbrosis nor
radiofrequency (RF) lesions can be visualized using DE-MRI in Japan,
mainly due to the differences in contrast agents, volume-rendering
tools and technical experience. Therefore, the objective of the
current study was to visualize RF lesions and tissue ﬁbrosis in the
left atrium (LA) of Japanese patients who underwent AF ablation
using commercially available tools for DE-MRI. In addition, we also
investigated the clinical differences between the successful and
unsuccessful MRI acquisitions groups.
2. Material and methods
2.1. Patient selection
The study was conducted in consecutive 15 patients who had
undergone AF ablation. DE-MRI scans were uninterpretable in
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3 patients because the imaging was performed too early after the
injection (n¼1) and owing to insufﬁcient respiratory gating (n¼2).
Therefore, the remaining 12 patients were enrolled in this study
and were subsequently divided into two groups according to the
quality of the acquired MRI (the adequate DE-MRI and the
inadequate DE-MRI groups). The study was approved by the local
institutional review board (Date: 11.19.2013; Approval number:
20), and written informed consent was obtained from all the
patients.
2.2. DE-MRI acquisition
All the patients underwent contrast-enhanced MR imaging
using a 1.5-T MR system (Intera Achieva; Philips Medical Systems)
equipped with a 32-channel cardiac coil. The scanning technique
and parameters for the DE-MRI have been previously reported
[5–8]. The DE-MRI of the left atrium (LA) with pulmonary veins (PVs)
was acquired using a 3D inversion recovery, respiration navigated,
electrocardiogram-gated, T1-FFE sequence in the transverse plane
15 min after the injection of 0.1 mmol/kg gadolinium (Magnevist;
Bayer HealthCare). Typical scan parameters were: repetition time
(TR)/echo time (TE)¼4.7/1.5, voxel size¼1.251.262.60 mm3
(reconstructed to 0.630.631.30 mm3), ﬂip angle¼15, inversion
time (TI)¼280–330 ms, SENSE with a reduction factor of 2, and 70
reference lines. The TI value was identiﬁed from the myocardial TInull
using a Look-Locker. The T1 of the LA wall was similar to the
myocardial T1 [5]. Data acquisition was limited to 15% of the cardiac
cycle. During the MRI, in sinus rhythm (SR) cases, data acquisition
was performed during the mid-diastolic phase of the left ventricle.
Furthermore, in AF cases, the trigger delay of the cardiac synchro-
nization was set to the shortest value. Saturation bands were placed
in the phase-encoding (right–left) line to minimize back-folding from
the arms. Fat saturation was applied to suppress any fat signals. The
typical scan time for the DE-MRI study was 7–12 min depending on
the heart rate (HR) and respiration pattern of each patient; we
attempted to maintain the HR at o70 bpm using metoprolol 20 or
40 mg.
2.3. 3D visualization of RF lesions and atrial ﬁbrosis
The method for 3D visualization of the lesions using DE-MRI
was as follows: ﬁrst, source images were transferred to a work-
station (AZE Virtual Place; AZE, Tokyo, Japan); second, segmenta-
tion was performed with AZE Virtual Place, and the LA was further
segmented semi-manually by contouring the endocardial and
epicardial borders of the atrium, including the PVs (Fig. 1); third,
a voxel-intensity histogram analysis of the LA wall measured the
intensities (41SD) of the Des, and the degree of intensity was
categorized into a color-coded scale (green: 1SD–2SD: yellow:
2SD–3SD; red: 44SD) [2]; and ﬁnally, 3D reconstruction of the LA
and PVs with the DEs was achieved automatically.
2.4. Statistics
Data were tested using the Kolmogorov–Smirnov test and are
presented as mean7standard deviation for normally distributed
variables. The medians and quartiles are given for non-normally
distributed variables. Categorical variables are expressed as num-
ber and percentage of patients. Continuous variables were ana-
lyzed using Student's t test. Categorical variables were analyzed
using Fisher's exact test. A value of po0.05 was considered
statistically signiﬁcant. All the statistical analyses were performed
with SPSS, Release 11.0 software (SPSS, Chicago, IL, USA).
3. Results
3.1. Patient characteristics
The patient characteristics are displayed in Table 1. The primary
AF type was paroxysmal AF in most patients (9/12 [75%]). Moreover,
the mean left atrial diameter and the mean left atrial appendage
(LAA) ﬂow were 4072 mm and 63725 cm/s, respectively.
Fig. 1. Adequate 3D visualization of an RF lesion in a patient without AF recurrence. (A) The LA wall slice 3 months after AF ablation observed using DE-MRI. The red arrows
show delayed enhancement. (B) 3D visualization of RF lesions. (C) AF ablation using the NavX system. The red and brown 3D tags indicate ablation points. The patient has
been free of any AF recurrence for 12 months after a single AF ablation, without using any anti-arrhythmic drug.
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3.2. Cardiac rhythm, heart rate, and usage of metoprolol during MRI
Data on cardiac rhythm, HR, and metoprolol use during MRIs are
displayed in Table 2. Most of the patients were in SR during the MRI.
The mean HR was controlled to around 70 bpm by using metoprolol.
3.3. Successful 3D visualization of the RF lesion: adequate
DE-MRI group vs. inadequate DE-MRI group
RF lesions were successfully visualized in 3D in 8 of the 12 patients
(67%). The quality of the MRI was inadequate in the remaining
4 patients who had undergone MRI immediately after AF ablation
(median of 3 days (2; 11) in the inadequate DE-MRI group vs. 44 days
(32; 300) in the adequate DE-MRI group, p¼0.004) (Table 3). Only one
patient had AF during the MRI, while the remaining 11 patients were
in SR. Furthermore, the HR was lower in the adequate DE-MRI group
than in the inadequate DE-MRI group (6875 bpm vs. 7979 bpm,
respectively, p¼0.021). The other clinical parameters did not differ
between the two groups (Table 3). Figs. 1 and 2 show representative
cases from the adequate and inadequate MRI groups, respectively;
both cases were free from AF. However, two cases (patients 1 and 2)
experienced AF recurrence during the MRI (Fig. 3). Of note, lesion gaps
were documented at the bottom of the right inferior pulmonary vein
(RIPV) and near the top of the right superior pulmonary vein (RSPV) in
patient 1 (Fig. 3A, B, and C) and at the roof of the left superior
pulmonary vein (LSPV) in patient 2 (Fig. 3D and E).
4. Discussion
4.1. Main ﬁndings
The visualization of the RF lesions and atrial ﬁbrosis using
DE-MRI has been thoroughly investigated by a group from the
University of Utah [2–4, 9–11]. Unfortunately, the complete visua-
lization of DE requires specialized software. Thus, the precise
methods for DE visualization clinically have still not been fully
established. The study presented here demonstrates that RF
lesions caused by AF ablation can be visualized using commercially
available tools. Moreover, in order to achieve adequate visualiza-
tion, the following are important: (1) A low HR (o70 bpm) during
the MRI (achieved using metoprolol in this study), and (2) the MRI
should be conducted at least 30 days after the AF ablation
procedure.
4.2. When should we conduct DE-MRI to visualize RF lesions
after AF ablation?
Peters et al. [5] reported that there was a signiﬁcant relation-
ship between DE thickness and the inverse of the number of days
since the ablation and showed that DE thickness dramatically
decreases with time, as the duration since AF ablation increases,
reﬂecting a decrease in inﬂammation and maturation of scar
tissue. This result is consistent with studies that have reported a
decline in DE among patients examined early after and subsequent
to myocardial infarctions. These results suggest that RF-induced
lesions show transient inﬂammatory changes and slow the devel-
opment of scar tissue, and that DE-MRI cannot adequately visua-
lize RF lesions 30 days after AF ablation. In our cases, DE-MRI could
not be used to visualize RF lesions in 4 (33%) of the 12 patients
who had undergone DE-MRI 2, 2, 3, and 14 days after AF ablation,
which is consistent with the results of a previous report [5].
Because inﬂammation and scar formation are stabilized, we
recommend DE-MRI should be used to assess RF lesions at least
60 days after AF ablation.
4.3. Is the control of HR essential for achieving an adequate DE-MRI?
This study demonstrated that a lower HR during MRI was
important for improving the quality of DE-MRI. As for the DE-MRI
acquisition, the University of Utah group reported that ECG gating
can be used to acquire a small subset of phase encoding views
during the diastolic phase of the left atrial cardiac cycle [2,11]. The
time interval between the R-peak of the ECG and the start of the
data acquisition was deﬁned by examining the cine images of the
left atrium in order to determine the period of minimal left atrial
Table 1
Clinical characteristics of the patient population.
Age (years) 5974
Male (n-%) 10(83)
Type of AF (n-%)
Paroxysmal 9(75)
Persistent 2(17)
Long-lasting 1(8)
AF history (months) 51(24; 81)
Antiarrhythmic drugs (n) 1(0; 1)
Arterial hypertension (n,%) 5(42)
Diabetes mellitus (n,%) 3(25)
Lone AF, (n-%) 4(33)
LAA ﬂow (cm/s) 63725
Left atrial diameter (mm) 4072
LV ejection fraction (%) 5671
AF¼atrial ﬁbrillation, LV¼ left ventricle, LAA¼ left atrial appendage.
Table 2
Cardiac rhythm, heart rate and usage of metoprolol during MRI.
Cardiac rhythm during MRI
Sinus rhythm (n-%) 11(92%)
Atrial ﬁbrillation (n-%) 1(8%)
Usage of metoprolol (n-%) 12(100%)
Dose of metoprolol
20 mg (n-%) 5(42%)
40 mg (n-%) 7(58%)
Heart rate (bpm) 7278
MRI¼magnetic resonance image.
Table 3
Clinical parameters grouped by the quality of the DE-MRI.
Adequate MRI
group
Inadequate MRI
group
P
value
(n¼8) (n¼4)
Cardiac rhythm during MRI 1.00
Sinus rhythm (n, %) 7(92%) 4(100%)
Atrial ﬁbrillation (n,%) 1(8%) 0(0%)
Use of metoprolol (n, %) 8(100%) 4(100%) N.A.
Dose of metoprolol 0.22
20 mg (n, %) 2(25%) 3(75%)
40 mg (n, %) 6(75%) 1(25%)
Heart rate (bpm) 6875 7979 0.021
Time to MRI (days) 44(32; 300) 3(2; 11) 0.004
After AF ablation
AF history (months) 51(27; 72) 73(12; 201) 0.067
Lone AF, (n, %) 3(38%) 1(25%) 0.81
LAA ﬂow (cm/s) 53721 82725 0.059
Left atrial diameter (mm) 4278 3775 0.35
LV ejection fraction (%) 5779 5479 0.61
MRI¼magnetic resonance image, AF¼atrial ﬁbrillation, LAA¼ left atrial appendage,
LV¼ left ventricle.
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Fig. 2. Inadequate 3D visualization of an RF lesion in a patient without an AF recurrence. (A) The LA wall slice observed using DE-MRI 2 days after the AF ablation; any
delayed enhancement (DE) caused by RF application was not visible. Of note, red arrows indicate artifacts, which may have been caused by the laser application to the right
hemi-diaphragm for respiratory navigation. (B) 3D visualization of the RF lesions. The red arrows indicate artifacts, not DE. (C) AF ablation using the CARTO3 system. The red
and pink 3D tags indicate the ablation points. The patient has been free from any AF recurrence for 6 months after a single AF ablation, without using any anti-arrhythmic
drug.
Fig. 3. Adequate 3D visualization of an RF lesion in a patient with an AF recurrence. (A) PA (postero-anterior) view. The red arrow indicates a gap near the RSPV. (B) Inferior
view. The red arrow indicates a gap at the bottom of the RIPV. (C) AF ablation using the NavX system in the ﬁrst session. A, B, C are all images from patient 1. Complete PVI
was accomplished without any RF applications to the LA posterior wall near the LPV. No DEs are visible in the same region in A. AF recurred 3 months following ablation in
the patient; inadequate lesion formation at the RPV may have caused the AF recurrence. (D) Cranial view. The red arrow indicates a gap near the roof of the LSPV. (E) AF
ablation using the NavX system in the second session. D and E are images from patient 2. The sharp potential was recorded at the gap of DEs. PV was re-isolated using a
single RF application at this site. RSPV¼right superior pulmonary vein, RIPV¼right inferior pulmonary vein, LSPV¼ left superior pulmonary vein, PVI¼pulmonary vein
isolation, LPV¼ left pulmonary vein, RPV¼right pulmonary vein.
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motion. They concluded that a typical value is an interval of 60% of
the mean RR interval for patients in SR. Obviously, a regular HR
and a long RR interval during each cardiac cycle can reduce the
cardiac motion, which results in achieving a better DE-MRI.
Nonetheless, we do not consider the observed differences in HR
(10 bpm) between the adequate DE-MRI group and the inade-
quate DE-MRI group in the current study (6875 vs. 7979 bpm)
to be critical because the precise anatomy of the PVs and the left
atrium could still be depicted in both groups (Figs. 1A and 2A). We
conclude that the impact of HR is likely less signiﬁcant for the
visualization of DE compared to that of the time from the AF
ablation to the MRI acquisition date (at least 430 days).
4.4. RF lesions assessed by DE-MRI and AF recurrence
McGann et al. reported that a gap in RF lesions at the PV
antrum analyzed using DE-MRI correlated with incomplete elec-
trical isolation [11]. In our study, during a follow-up of 5.372.5
months, AF recurred in 2 (17%) of the 12 patients. Moreover, DE-
MRI showed a gap in the RF lesions in both patients (Fig. 3).
An inadequate RF lesion formation could cause PV-LA reconduc-
tion. In contrast, a complete RF lesion formation without a gap was
clearly demonstrated in the remaining 10 patients without AF
recurrences. These ﬁndings are complimentary to those of the
University of Utah group, and the quality of the visualization
appears to be equivalent to that obtained in their work [11].
4.5. What is different from the University of Utah protocol?
The DE-MRI acquisition was conducted according to the Uni-
versity of Utah protocol. However, the differences in the protocol
are as follows: (1) The TE of the scan (2.3 ms) was “not” chosen to
ensure that fat and water are out of phase. (2) The ECG gating was
used to acquire a subset of phase-encoding views during the mid-
diastolic phase of the “left ventricle (LV)” cardiac cycle, whereas
the diastolic phase of the “LA” was used previously.
The University of Utah group suggested that the TE of the scan
be chosen so that fat and water are “out of phase”, and that the
signal intensity of partial volume fat-tissue voxels are reduced,
allowing for an improved delineation of the LA wall boundary
(“paradoxical suppression”) [7,8]. However, in this study, we chose
not to follow this part of the protocol to avoid any unexpected
suppression of the LA anatomy. Furthermore, with our method, we
noted dramatically less motion artifact of the LA when ECG gating
was used during the mid-diastolic phase of the “left ventricle”
cardiac cycle than that during the diastolic phase of the LA [12].
We believe that our protocol actually allowed for the identiﬁcation
of a precise LA wall boundary without using the “paradoxical
suppression” technique. Our typical mean RR interval value was
70% for patients in SR. In the 2 cases of AF that occurred during the
MRI, the LA motion differed during each cardiac cycle throughout
AF even after using ECG gating. Thus, the trigger delay of the
cardiac synchronization was set to the shortest value. Therefore,
the impact of the ECG gating was likely to be less in patients with
AF than in those with SR.
4.6. Study limitations
Our study has three major limitations. First, the sample size was
relatively small. Second, the relationship between the gap assessed
by DE-MRI and the PV-LA reconduction could not be demonstrated
because no follow-up AF procedures were performed; this relation-
ship should be investigated in a further study. Third, while most of
the patients were in SR during MRI acquisition, we were unable to
determine image quality of MRI in patients with AF during MRI
acquisition. Finally, we may have overestimated the size of the RF
lesion, because we had not previously assessed the original atrial
ﬁbrosis using DE-MRI before AF catheter ablation.
5. Conclusion
To adequately visualize RF lesions, an MRI acquisition should be
performed at least 30 days after AF ablation in patients preferably
with a low HR in SR. By improving some of the clinical and
procedural parameters during MRI, we could visualize RF lesions
using DE-MRI, although we used only commercially available tools.
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